Cell Culture Technology– category –
-
Viral Vector Packaging Services Market Signals Rapid Growth Driven by Gene Therapy Commercialization and Increased Biomanufacturing Investment
openPR.com USA Overview This article provides an overview of a market research report from openPR.com. The global viral vector packaging services market is experiencing rapid growth, driven by advancing gene therapy commercialization and... -
Hilleman Laboratories Officially Opens US$20 Million cGMP Facility in Singapore to Bolster Vaccine Manufacturing Resilience
EDB Singapore Singapore Overview Hilleman Laboratories has officially opened a new US$20 million cGMP manufacturing facility in Singapore. The 30,000 sq ft facility aims to produce affordable vaccines and biologics, enhancing the resilie... -
WuXi Biologics Breaks Ground on $1.4 Billion CRDMO Center in Singapore, Boosting Global Manufacturing Capacity by 120,000 Liters
EDB Singapore China Overview WuXi Biologics has broken ground on a new $1.4 billion Contract Research, Development, and Manufacturing Organization (CRDMO) center in Singapore's Tuas Biomedical Park. This massive investment will add 120,0... -
Huazhong University of Science and Technology Tongji Hospital Demonstrates In Vivo CAR-T Therapy, Achieving Cost Reduction and Immune Reset for Multiple Sclerosis
Chosunbiz South Korea Overview A research team at Huazhong University of Science and Technology Tongji Hospital has demonstrated in vivo CAR-T therapy for autoimmune diseases like multiple sclerosis, successfully reducing manufacturing a... -
Allogeneic Cell Therapy Manufacturing: Challenges, Advantages, and the Key Role of Automated Bioreactors for Scalability
sdg.azte.co Global Overview This article delves into the complexities of allogeneic cell therapy manufacturing, highlighting its advantages such as scalability, off-the-shelf availability, and cost-effectiveness. The manufacturing proces... -
CDMO Signal Ranks Viral Vector CDMOs: Thermo Fisher Scientific, AGC Biologics, and Takeda Lead Top Tier
CDMO Signal USA Overview CDMO Signal released its latest ranking of viral vector CDMOs, including AAV, lentiviral, and adenoviral modalities. Thermo Fisher Scientific, AGC Biologics, and Takeda secured top positions in the overall Signal... -
GentiBio Publishes in EMBO Molecular Medicine, Detailing Technology Enabling Durable Persistence of Allogeneic T-Cell Therapies
GentiBio (Press Release) USA Overview GentiBio announced the publication in EMBO Molecular Medicine of a paper detailing an innovative technology enabling durable in vivo persistence of allogeneic T-cell therapies. This approach addresse... -
RayzeBio to Invest $173 Million in Radiopharmaceutical Manufacturing Plant to Accelerate Production Expansion
Fierce Biotech USA Overview RayzeBio announced plans to invest $173 million in the construction of a new radiopharmaceutical manufacturing plant, significantly expanding its production capacity. This substantial investment aims to meet t... -
Winship Cancer Institute Launches Cellular Therapy Initiative, Expanding GMP Manufacturing Capacity for Next-Generation Cancer Treatments
Winship Cancer Institute USA Overview The Winship Cancer Institute has launched a Cellular Therapy Initiative to accelerate the development of next-generation cancer treatments. This initiative significantly expands GMP manufacturing cap... -
Lonza Appoints Samanta Cimitan as Chief Commercial Officer (CCO) to Enhance Customer Engagement and Accelerate Growth
Fierce Pharma Switzerland Overview Lonza announced the appointment of Samanta Cimitan as its new Chief Commercial Officer (CCO), effective January 1, 2027. This strategic move aims to integrate Lonza's strategic enterprise account manage...
